![Louis P. Lacasse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Louis P. Lacasse
Président chez
Centre For Commercialization of Cancer Immunotherapy
Profil
Louis P.
Lacasse currently works at Centre For Commercialization of Cancer Immunotherapy, as Chairman, Aegera Therapeutics, Inc., as Director, Bellus Health (Innodia), Inc., as Director, AgeChem Financial, Inc., as Director, and GeneChem Management, Inc., as General Partner from 1997.
Mr. Lacasse also formerly worked at AmpliPhi Biosciences Corp., as Director from 1998 to 2006, Aptalis Pharma Canada ULC, as Director, Warnex, Inc., as Independent Director from 2012 to 2013, Chromos Molecular Systems, Inc., as Director, Idun Pharmaceuticals, Inc., as Director, Advitech, Inc., as Director from 2009 to 2011, Conatus Pharmaceuticals, Inc., as Independent Non-Executive Director from 2013 to 2016, Biochem Pharma, Inc., as Director, Mirati Therapeutics, Inc., as Independent Director in 2012, Emerillon Therapeutics, Inc., as Director, Alethia Biotherapeutics, Inc., as Director, Calyx Ventures, Inc., as Independent Director from 2012 to 2013, Natunola AgriTech, Inc., as Director, Nuchem Therapeutics, Inc., as Director, Bank of Montreal, as Account Manager, National Bank of Canada, as Financial Analyst from 1978 to 1979, The Caisse de dépôt et placement du Québec, as Vice President in 1997, SOFINOV Société Financière d'Innovation, Inc., as Vice President-Healthcare & Biotechnology from 1987 to 1997, and CDP Capital Private Equity, as Vice President from 1988 to 1997.
Mr. Lacasse received his Masters Business Admin degree from McGill University and undergraduate degree from École des Hautes Études Commerciales de Paris.
Postes actifs de Louis P. Lacasse
| Sociétés | Poste | Début |
|---|---|---|
GeneChem Management, Inc.
 GeneChem Management, Inc. Investment ManagersFinance GeneChem invests in companies located primarily in the US, Canada and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for seed to later-stage mezzanine rounds and private placements in publicly listed companies. | Private Equity Investor | 13/01/2011 |
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Directeur/Membre du Conseil | - |
AgeChem Financial, Inc.
 AgeChem Financial, Inc. Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | 01/01/1997 |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Directeur/Membre du Conseil | - |
Centre For Commercialization of Cancer Immunotherapy
 Centre For Commercialization of Cancer Immunotherapy BiotechnologyHealth Technology Manufactures cell and gene products | Président | - |
Anciens postes connus de Louis P. Lacasse
| Sociétés | Poste | Fin |
|---|---|---|
| HISTOGEN INC. | Directeur/Membre du Conseil | 23/06/2016 |
| CALYX VENTURES INC. | Directeur/Membre du Conseil | 16/10/2013 |
| WARNEX INC. | Directeur/Membre du Conseil | 29/04/2013 |
| MIRATI THERAPEUTICS | Directeur/Membre du Conseil | 12/11/2012 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Louis P. Lacasse
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
Bank of Montreal
 Bank of Montreal Major BanksFinance Provides national banking services | Finance |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
National Bank of Canada
 National Bank of Canada Major BanksFinance Provides personal & commercial banking, financial markets brokerage and wealth management services | Finance |
The Caisse de dépôt et placement du Québec
 The Caisse de dépôt et placement du Québec Investment ManagersFinance CDPQ uses constructive capital to create new opportunities and position businesses for success – in private equity, equity markets, private credit, infrastructure and real estate. Each asset class has a specific risk-return profile and brings together various specialized portfolios and mandates. These are composed of liquid and less liquid securities and are managed in an integrated manner mainly internally. They are convinced that sustainable investing is a fundamental vector of long-term returns. | Finance |
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Warnex, Inc.
 Warnex, Inc. Medical SpecialtiesHealth Technology Provides laboratory services to the pharmaceutical and healthcare sectors | Health Technology |
Chromos Molecular Systems, Inc.
 Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutics and conducts medical research | Health Technology |
Advitech, Inc.
 Advitech, Inc. BiotechnologyHealth Technology Manufactures bioactive ingredients | Health Technology |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of human therapeutics to treat liver diseases | Health Technology |
SOFINOV Société Financière d'Innovation, Inc.
 SOFINOV Société Financière d'Innovation, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products focused on infectious diseases and cancer | Health Technology |
CDP Capital Private Equity
 CDP Capital Private Equity Investment ManagersFinance CDPQ invests in ESG companies located in the United States, Europe, Latin America, Canada and Asia-Pacific regions. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size ranging from CAD 75 - 500 million. It acquires minority stake. | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Health Technology |
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
GeneChem Management, Inc.
GeneChem Management, Inc. Investment ManagersFinance GeneChem invests in companies located primarily in the US, Canada and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for seed to later-stage mezzanine rounds and private placements in publicly listed companies. | Finance |
Emerillon Therapeutics, Inc.
 Emerillon Therapeutics, Inc. BiotechnologyHealth Technology Used to develop genomics-based drugs for human complex diseases | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgeChem Financial, Inc.
AgeChem Financial, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Health Technology |
Calyx Ventures, Inc.
 Calyx Ventures, Inc. Information Technology ServicesTechnology Services Develops custom software for enterprises and start-up companies | Technology Services |
Natunola AgriTech, Inc.
 Natunola AgriTech, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets proprietary natural ingredients | Health Technology |
Nuchem Therapeutics, Inc.
 Nuchem Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and chemical development contract research organization | Commercial Services |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy BiotechnologyHealth Technology Manufactures cell and gene products | Health Technology |
Choisissez Zonebourse 
